Research has indicated that MIIP has the capability to expedite the degradation of EGFR while concurrently suppressing the downstream Ras/MEK/ERK signaling cascade, consequently curbing the proliferation and metastasis of non-small cell lung cancer (Wen et al. 2016). The gene discussed is MAP2K7; the disease is non-small cell lung carcinoma.